Pacira BioSciences, Inc.
PCRX
$23.00
-$0.18-0.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 111.48% | 104.95% | 107.07% | 123.63% | -300.43% |
| Total Depreciation and Amortization | -4.82% | 12.08% | 15.77% | 12.60% | 21.51% |
| Total Amortization of Deferred Charges | -30.49% | -20.01% | -6.98% | 7.38% | 19.33% |
| Total Other Non-Cash Items | -62.58% | -55.99% | -60.67% | -56.63% | 193.98% |
| Change in Net Operating Assets | 107.49% | -209.24% | -215.44% | -577.58% | -141.23% |
| Cash from Operations | 39.50% | -19.08% | -19.75% | -30.61% | -30.79% |
| Capital Expenditure | 53.32% | 41.83% | -44.16% | -67.05% | -81.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 97.99% | 97.99% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 465.14% | 355.94% | 281.05% | 277.08% | 206.23% |
| Cash from Investing | 688.53% | 254.81% | 219.46% | 207.04% | 40.12% |
| Total Debt Issued | -- | -64.87% | -64.87% | -64.87% | -100.00% |
| Total Debt Repaid | -2,535.67% | -51.73% | -50.70% | -49.66% | 94.83% |
| Issuance of Common Stock | 56.41% | 43.82% | 43.73% | 0.48% | -0.99% |
| Repurchase of Common Stock | -183.51% | -710.99% | -503.92% | -313.91% | -118.20% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 93.94% | 93.94% | 93.89% | 100.00% |
| Cash from Financing | -476.08% | -2,578.94% | -2,228.82% | -1,924.11% | -782.06% |
| Foreign Exchange rate Adjustments | -219.12% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -277.07% | -239.92% | -195.75% | -166.99% | -66.66% |